Quick Answer
REGENEREX PHARMA, INC. reported Stockholders Equity of -$4.16 million for the year ending 2025.
- REGENEREX PHARMA, INC. showed a decrease of -2.3% in Stockholders Equity from 2024 to 2025.
- This data is from REGENEREX PHARMA, INC.'s annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2008: -$2.5 thousand | Q4 2009: -$8.5 thousand | Q3 2010: -$13.8 thousand | Q4 2010: -$22.8 thousand | Q3 2011: $339.1 thousand | Q2 2012: -$280.6 thousand | Q3 2012: -$285.1 thousand | Q1 2014: -$1.86 million | Q2 2014: -$693.5 thousand | Q3 2014: -$742.7 thousand | Q2 2017: -$298.8 thousand | Q3 2017: -$306.9 thousand | Q4 2017: -$317.4 thousand | Q2 2018: -$339.7 thousand | Q3 2018: -$344.5 thousand | Q4 2018: -$353.2 thousand | Q2 2019: -$402.0 thousand | Q3 2019: -$420.4 thousand | Q4 2019: -$441.0 thousand | Q2 2020: -$491.1 thousand | Q3 2020: -$516.9 thousand | Q4 2020: -$550.5 thousand | Q2 2021: -$869.0 thousand | Q3 2021: -$902.7 thousand | Q4 2021: -$937.2 thousand | Q2 2022: -$1.01 million | Q3 2022: -$1.03 million | Q4 2022: -$1.08 million | Q2 2023: -$1.08 million | Q3 2023: -$3.63 million | Q4 2023: -$3.88 million | Q1 2024: -$4.06 million | Q2 2024: -$4.31 million | Q3 2024: -$4.76 million | Q4 2024: -$5.05 million | Q1 2025: -$4.16 million | Q2 2025: -$4.55 million | Q3 2025: -$4.70 million.
- Over the full 15 years of available data (2010 to 2025), REGENEREX PHARMA, INC.'s Stockholders Equity has declined by 26,912.5%.
- Historical annual values: Fiscal year 2025: -$4.16 million | Fiscal year 2024: -$4.06 million | Fiscal year 2023: -$1.12 million | Fiscal year 2022: -$985.6 thousand | Fiscal year 2021: -$835.0 thousand | Fiscal year 2020: -$481.3 thousand | Fiscal year 2019: -$369.7 thousand | Fiscal year 2018: -$321.1 thousand | Fiscal year 2017: -$321.1 thousand | Fiscal year 2016: -$279.1 thousand | Fiscal year 2014: -$795.4 thousand | Fiscal year 2013: -$1.70 million | Fiscal year 2012: -$749.7 thousand | Fiscal year 2011: -$122.3 thousand | Fiscal year 2010: $15.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: